Literature DB >> 3338655

Bladder and rectal complications following radiotherapy for cervix cancer.

J A Stryker1, M Bartholomew, D E Velkley, D E Cunningham, R Mortel, G Craycraft, J Shafer.   

Abstract

One-hundred and thirty-two patients with cervix carcinoma who were treated with whole pelvis irradiation and two intracavitary applications had bladder and rectal dosimetry during brachytherapy with contrast agents placed into the bladder and rectum prior to orthogonal simulator radiographs. Doses were computer calculated at points A and B, F (bladder), R1 (rectum), and R2 (rectosigmoid). Late occurring bladder and rectal complications were graded on a severity scale of 1 to 3, and 14% had grade 2 or 3 injuries (9% developed fistulas). Statistical evaluation of the data showed that severe bladder and rectal injuries occur more commonly in stage IIIA and IIIB disease and in those receiving high external beam doses (5000 rad +). Analysis of variance tests revealed a significant correlation of brachytherapy dose to points R1 and R2 with severe rectal injuries but there was not a correlation of dose to F with bladder injuries. Nor was there correlation of injuries with dose to point A or the milligram-hour dose. We conclude that our technique for rectal dosimetry is adequate but that an improved technique of bladder dosimetry is needed. Also, when combining whole pelvis irradiation with two intracavitary applications (4000 rad to point A), the whole pelvis dose should probably not exceed 4000-4500 rad.

Entities:  

Mesh:

Year:  1988        PMID: 3338655     DOI: 10.1016/0090-8258(88)90140-0

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

1.  Radiotherapy versus radiochemotherapy with cisplatin in treatment of cervical cancer.

Authors:  Bogdan Torbé; Michał Falco; Andrzej Torbé; Przemysław Ciepiela; Rafał Kurzawa
Journal:  Med Oncol       Date:  2009-01-07       Impact factor: 3.064

2.  Influence of brachytherapy applicators geometry on dose distribution in cervical cancer.

Authors:  E Senkus-Konefka; A Kobierska; J Jassem; K Serkies; A Badzio
Journal:  Strahlenther Onkol       Date:  1997-06       Impact factor: 4.033

3.  2D to 3D Evaluation of Organs at Risk Doses in Intracavitary Brachytherapy for Cervical Cancer.

Authors:  Yun Inn Tan; Bok Ai Choo; Khai Mun Lee
Journal:  J Contemp Brachytherapy       Date:  2010-04-01

4.  Positional variation of applicators during low dose rate intracavitary brachytherapy for cervical cancer: a prospective study.

Authors:  Kirthi Koushik; Ramesh Bilimagga; Nirmala Rao; M G Janaki; Arul Ponni; A G Rajeev
Journal:  J Contemp Brachytherapy       Date:  2010-10-13

5.  Evaluation of variation in dose of organs at risk in intracavitary brachytherapy of cervical cancer - a prospective study.

Authors:  Brahmacharimayum Arunkumar Sharma; Th Tomcha Singh; L Jaichand Singh
Journal:  J Contemp Brachytherapy       Date:  2011-03-31

6.  Optimal bladder filling during high-dose-rate intracavitary brachytherapy for cervical cancer: a dosimetric study.

Authors:  Umesh Mahantshetty; Saurabha Shetty; Dipanjan Majumder; Pranjal Adurkar; Jamema Swamidas; Reena Engineer; Supriya Chopra; Shyamkishore Shrivastava
Journal:  J Contemp Brachytherapy       Date:  2017-04-30

7.  Biological effective doses in the intracavitary high dose rate brachytherapy of cervical cancer.

Authors:  B Arunkumar Sharma; Th Tomcha Singh; L Jaichand Singh; Y Indibor Singh; Y Sobita Devi
Journal:  J Contemp Brachytherapy       Date:  2011-12-30

8.  Retroperitoneoscopic ureterocutaneostomy as a method of urinary diversion in case of complicated urinary fistula after radiotherapy.

Authors:  Marcin Słojewski; Bogdan Torbé
Journal:  Cent European J Urol       Date:  2011-09-06

9.  Dosimetric analysis of the effects of the bladder volume on organs at risk (OAR) in high-dose-rate intracavitary brachytherapy in carcinoma cervix - an institutional study.

Authors:  Ashutosh Das Sharma; Jyoti Poddar; U Suryanarayan K; Sonal Patel Shah; Ankita Parikh; Vimesh Mehta; Med Phys; Tarun Kumar; Med Phys
Journal:  J Contemp Brachytherapy       Date:  2018-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.